News

You are here

May 17, 2017

On Wednesday, 31st of May 2017, Iproteos will celebrate the Trade Union assembly. More information is given in the link below.

El Miércoles, 31 de Mayo de 2017, Iproteos celebrará una Asamblea del Sindicato de Voto. Se puede encontrar toda la información necesaria en el siguiente enlace: 

ASAMBLEA DEL SINDICATO 31 DE MAYO DE 2017.pdf

Apr 10, 2017

Barcelona hosted BIO-Europe Spring 2017, one of the reference events for European biotech and pharma companies. Iproteos not only participated in the partnering, but it also was selected to participate in the Startup Slam, a pitching competition organized by Johnson&Johnson Innovation and EBD Group.

Jan 26, 2017

The Spanish Ministry of Economy, Industry and Competitiveness has granted a project for the validation of a new family of drug candidates for the treatment of vascular cholesterol accumulation associated with atherosclerosis.

Dec 19, 2016

Iproteos, in collaboration with the group of Prof. Javier Meana, from the University of Basque Country and CIBERSAM, and Prof. Giralt, from IRB Barcelona, has just published an article at European Neuropsychopharmacology. The paper, entitled "The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia", describes the efficacy of a novel procognitive drug for the treatment of Cognitive Impairment Associated to Schizophrenia (CIAS).

Oct 25, 2016

Iproteos has closed a funding round of 1.5M €, led by Caixa Capital Risc and with participation of Kinled Holding, a Hong Kong based investment company with offices in London, New York and Zurich, and the biotech Ascil Biopharm.